DBVT FY 2017 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$538M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M+45.3% YoY

Gross Profit

$12M100.0% margin

Operating Income

-$174M-1510.0% margin

Net Income

-$177M-1538.3% margin

EPS (Diluted)

$-42.00

Cash Flow

Operating Cash Flow

-$161M

Free Cash Flow

-$172M

Stock-Based Comp.

$43M

Balance Sheet

Total Assets

$250M

Total Liabilities

$67M

Stockholders' Equity

$183M

Cash & Equivalents

$194M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$8M	+45.3%
Gross Profit	$12M	$8M	+45.3%
Operating Income	-$174M	-$122M	-42.4%
Net Income	-$177M	-$126M	-40.2%